Redwire Corporation vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Redwire Corporation trades at $9.48 (market cap $2.44B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.51 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 10.4× Redwire Corporation's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Redwire Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Redwire Corporation for 18 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| RDW | RPRX | |
|---|---|---|
Market Cap | $2.44B | $25.27B |
Volume | 11,053,212 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $25.90 | $63.96 |
52-Week Low | $5.06 | $35.44 |
Typical Hold Time | 18 Days | 0 Days |
Enterprise Value | $1.97B | $32.50B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
Redwire Corporation (RDW) trades at $9.53, down 6.93% on the day, with technical indicators showing bearish momentum despite oversold RSI readings. The company reported negative earnings with Q2 2026 EPS of -$0.19 missing expectations, while revenue grew to $335.38M in 2025. Recent positive developments include a $981M Space Force contract award and partnerships with Honda and Sophia Space for robotics and orbital data centers.
Despite strong analyst support (80% buy ratings) and a $14.88 price target representing 56% upside, RDW faces significant fundamental challenges with negative profit margins and cash burn. The stock presents a high-risk opportunity for investors betting on space infrastructure growth, but requires careful monitoring of profitability improvements and execution on contract wins.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →